Copyright © 2017 bigstocks.io All rights reserved
“I've been using CaniSun sunscreen and I love the product. This is an easy endorsement for someone who's in the sun as much as i am.”
ERNIE ELS
Our Opinion
Based on the prospects of JUPW new products, patents, and clinical testing results, and considering the company's cheap stock price and market capitalization, JUPW offers extensive upside for potential investors. JUPW may be the best stock to buy in 2022.
Get JUPW Updates Start Winning.
More About JUPW
Here's what you should know about Jupiter Wellness:
Jupiter Wellness inc.
(JUPW) hair loss and sexual health product with IP licensing deals worldwide makes this a stock to invest in.
(JUPW) conducts research, develops products, licenses its IP's, and technologies and products that can generate long-term profitability and sustainable cash flows, a stock to watch for long term investment.
(JUPW) is at the FOREFRONT of hair loss industry with Minoxidil boosters, an explosive product line with stunning projections making JUPW a huge stock pick.
JUPW Develops IP, skincare, and Sexual health products.
With a focus on hair, skin and sexual health, JUPW has several new patented product launching worldwide. Minoxidil boosters for hair growth, Treatments for eczema, first degree burns, Sunscreen for Jellyfish stings and others.
JUPW initiates clinical study of CaniSun for the treatment of (Skin Cancer)
CaniSun is an over-the-counter product, which is an effective sunscreen that may act as a prophylactic treatment to prevent AK from occurring or to inhibit its progression into squamous cell carcinoma (skin cancer).
3 reasons to put JUPW in your portfolio:
1. JUPW is a global leader in an industry projected to grow to $73.6 Billion as per Forbes by the year 2027.
2. JUPW is set for extensive growth thanks to cutting-edge Minoxidil Booster treatments transforming the Hair loss industry. Jupiter Wellness has a number of products in final-stage trials and ready to go to market.
3. JUPW has licensing deals with Taisho, a $2.6 billion revenue company and Japan’s leading seller of minoxidil products. A $300k up-front payment was received with 3% royalties on net sales. They expect to launch the product commercially in 2023. Also Licensed to India-based Cosmofix Technology and Sanpelle.
JUPW presents a compelling buying opportunity for investors.
JUPW's IPO was in October 2020. This company has grown substantially since its IPO. JUPW is still very much under the radar, and this presents a huge opportunity for investors looking for the best stock to buy right now.
Favorable Projections
The hair loss, and sexual health industry is massive. JUPW is licensing its IP's worldwide, and with its strong revenue trajectory, JUPW could easily see its market cap grow to $500 Million.
Ready To Make Money With (JUPW)?
Always do your own research on (JUPW).
Ready To Make Money With (MOCI)?
Always do your own research on (MOCI). To proceed.... Click on any of these online brokerages below or call your broker.
Disclaimer:
Disclaimer:
Ready To Make Money With JUPW?
Always do your own research on (JUPW).
This website/newsletter is owned, operated and edited by Stellar Partners LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” or “Stellar Partners” refers to Stellar Partners LLC. This webpage/newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis for making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. Stellar Partners business model is to receive financial compensation to promote public companies. Pursuant to an agreement between Stellar Partners LLC and Penzance LLC (a non affiliated 3rd party), Stellar Partners has been hired for a period beginning on 3/15/23 and ending on 6/15/23 to conduct investor relations advertising and marketing and publicly disseminate information about (jupw) via Website, Email and SMS. We have been paid one hundred and fifty thousand dollars via bank wire transfer. We expect to receive additional compensation as the investor awareness continues. We own zero shares of (jupw). This compensation is a major conflict of interest in our ability to be unbiased regarding. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, Stellar Partners often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. See full disclaimer at http://bigstocks.io/disclaimer
Nasdaq STOCK PICK:
(JUPW)
This $.31 stock may soar 371% Here's why...
This $0.97 Nasdaq stock may soar. Here's why
Nasdaq Stock Pick:
(JUPW)
BigStocks.io
Products endorsed by Legend Ernie Els
Jupiter Wellness Inc. News:
Will Jupiter Wellness Innovative New Product Sway Investors?
Jupiter Wellness Stock: Updates After Merging With Next Frontier
Stock Alert
JUPW Small Cap Research Report
March 24th 2023
"Potential Short Squeeze Expected"
